
Yi Lin/x
Apr 14, 2025, 09:30
Yi Lin: Bispecific antibodies therapies in multiple myeloma
Yi Lin, Professor at Mayo Clinic Comprehensive Cancer Center, shared a post on X:
“Now delving into bispecific antibodies therapies in multiple myeloma at iwCART25.
We have 3 antigen targets, dual & triple targets in clinic & trials. How best to optimize their use?
Rakesh Popat starts with Cevostamab data.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 12:02
Apr 15, 2025, 11:54
Apr 15, 2025, 11:52
Apr 15, 2025, 11:46
Apr 15, 2025, 11:30
Apr 15, 2025, 11:00
Apr 15, 2025, 10:23